New Statin Drug Out

Crestor, a relative newcomer to the stain market, will soon contend with what some experts have labeled "a formidable rival." U.S. pharmaceutical giants, Merck & Co. and Schering-Plough, are expected to win federal clearance later this month to jointly market Vytorin, which combines in a single pill two older cholesterol medications, Zocor and Zetia. Merck and Schering-Plough are expected to portray Vytorin as on par with Crestor in terms of effectiveness at lowering cholesterol, but...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports